$AEHR

SCOTT GEOFFREY GATES sold $1.6M of AEHR (indirect holdings)

SCOTT GEOFFREY GATES (Director) sold 20,000 indirectly-held shares of AEHR TEST SYSTEMS (AEHR) at $82.13 ($1.64M total) on 2026-07-16.

Original reporting
SEC EDGAR · SCOTT GEOFFREY GATES
Published Jul 17, 2026, 6:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 17, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this filing alone does not change AEHR’s operating outlook.

02

Market read

A director’s open-market sale at $82.1325 is disclosed, which may slightly affect sentiment but provides no new fundamental information.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, which can increase interpretive noise, but it still lacks any linkage to earnings, guidance, or business developments.

Relevance 6/10Novelty 3/10Timing: after-hours filing timestamp on 2026-07-17 for a 2026-07-16 sale

Background

The article is an SEC Form 4 insider transaction disclosure for AEHR director Scott Geoffrey Gates.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

Director Scott Geoffrey Gates filed an open-market sale of 20,000 AEHR shares at $82.1325 on 2026-07-16, leaving 30,000 shares.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

Form 4 insider sales are common and the filing provides transaction details but no new company-specific operating or guidance information.

Market effects

None; this is company-specific insider transaction data.

None.

None.

Counterpoint

The sale may be unrelated to company outlook (taxes, diversification, or pre-existing personal liquidity needs), so price impact may be overstated.

Key entities

  • AEHR

    AEHR Test Systems, the company whose director insider sale was disclosed.

  • Scott Geoffrey Gates

    Director of AEHR who sold 20,000 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRHigh

AEHR Stock Jumps As Oppenheimer Targets AI Test Boom

Aehr Test Systems (AEHR) stock rose 7.06% on strong semiconductor test demand and AI-driven growth prospects. Oppenheimer initiated an Outperform rating with a $120 target, citing a $41M hyperscaler order. AEHR reported $18.8M revenue, $1.39M net income, and a strong balance sheet. The stock has gained 32% in a month, driven by AI and EV themes.

$AEHRMed

AEHR Stock Rides AI Order Wave Amid Volatility

Aehr Test Systems (AEHR) stock rose 13.28% following strong earnings and a positive outlook for semiconductor test demand. The company reported $50M in revenue, $18.8M in quarterly revenue, and a net income of $1.39M. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI production. The stock has shown volatility, with a recent drop of 9.5-10.5% in a single session. Insiders have sold shares but maintain significant holdings. AEHR is actively presenting a

$AEHRHigh

AEHR Stock Rallies As AI Orders And Wall Street Support Build

Aehr Test Systems (AEHR) stock rose 11.71% due to strong AI-related demand. The company reported $18.8M in revenue with a 35.3% gross margin. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI chip production. The company has a strong balance sheet and a $22M follow-on order from a major customer.